P. Divya Jyothi, T. Vinay kumar, K. Swetha, S. Samatha, G. Satya Sree
P. Divya Jyothi1*, T. Vinay kumar2 K. Swetha3, S. Samatha3, G. Satya Sree3
1Assistant Professor, Department of Pharmacy Practice, Nirmala College of Pharmacy, Atmakur.
2Professor, Department of Pharmacy Practice, Nirmala College of Pharmacy, Atmakur.
3Interns, Department of Pharmacy Practice, Nirmala College of Pharmacy, Atmakur.
Volume - 13,
Issue - 12,
Year - 2020
Diabetes could be a chronic, metabolic illness characterised by elevated levels of blood sugar, that leads over time to serious harm to the guts, blood vessels, eyes, kidneys, and nerves. The foremost common is type two polygenic disease, typically in adults, that happens once the body becomes immune to hypoglycemic agent or does not build enough hypoglycemic agent. Within the past 3 decades the prevalence of type two polygenic disease has up dramatically in countries of all financial gain levels. The main aim of the study provides overview prevalence, drug utilization by using WHO-INRUD (International Network of Rational Use of Drugs) drug core indicators in diabetic patients at tertiary care hospital. The drug utilization studies are focused to study prescription habits of medical practitioners. These studies aims to analyse the type of drugs prescribed, their dosing schedule, and the adequacy of the prescription for a specific diagnosis. The obtained data during the ward rounds were thoroughly analysed to evaluate rationality in drug using. In our study a total of 100 prescriptions were analysed and the most prescribed therapy was Insulin therapy (63%). When coming to oral hypoglycaemic drugs Sulphonylureas (7%) and Biguanides (7%) were more frequently prescribed which indicates their significant role in pharmacotherapy of diabetes, most of the prescriptions were prescribed in combinations in which dual therapy (87%) was most prescribed followed by triple therapy (13%). All the prescriptions were analysed for their compliance to WHO drug core indicators. The results implies that there is an increased need for prescribing generically as it is cost effective and has less potential for errors. Therefore it is advisable for all prescribers to prescribe generically.
Cite this article:
P. Divya Jyothi, T. Vinay kumar, K. Swetha, S. Samatha, G. Satya Sree. A Study on Evaluation of Prescribing Pattern in Diabetic patients at Tertiary Care Hospital. Research J. Pharm. and Tech. 2020; 13(12):5881-5884. doi: 10.5958/0974-360X.2020.01025.2
P. Divya Jyothi, T. Vinay kumar, K. Swetha, S. Samatha, G. Satya Sree. A Study on Evaluation of Prescribing Pattern in Diabetic patients at Tertiary Care Hospital. Research J. Pharm. and Tech. 2020; 13(12):5881-5884. doi: 10.5958/0974-360X.2020.01025.2 Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2020-13-12-40
4. M. Sujatha Kumari, M. Kiran Babu, Rehana Sulthana, M. Srinivas, Ch. Prasanthi. Diabetes Mellitus: Present status and Drug therapy Updates. Research J. Pharm. and Tech. 7(1): Jan. 2014; Page 84-94.
5. Merry Raphael, Vijayanarayana K, Girish Thunga, Karthik Rao N, Sreedharan N. Utilization Pattern of Anti-Diabetic Drugs in Type 2 Diabetes Mellitus in Tertiary Care Hospital. Research J. Pharm. and Tech. 2017; 10(7): 2063-2068.
6. Abinaya. S.K, Vijey Aanandhi. M. An Improvement in Patient Compliance in Diabetes Mellitus. Research J. Pharm. and Tech 2018; 11(2):587-592.
7. S. Preethikaa, M. P. Brundha. Awareness of Diabetes Mellitus among General Population. Research J. Pharm. and Tech 2018; 11(5):1825-1829
8. Vanmathi. S. M, Monitha Star. M, Jishala. M. I, Shanmuga Sundaram. R. A Pathophysiological Approach of Macrovascular Complication in Diabetes Mellitus with Hypertension: A Systematic Review. Research J. Pharm. and Tech 2019; 12(2):901-906.
9. Subhadeep Chowdhury, Subhabrota Majumdar. Fixed Dose Combination - its Rationality and Safety. Research J. Pharm. and Tech.3 (3): July-Sept. 2010; Page 705-708.
10. Hazaratali Panari, Vegunarani. M. Study on Complications of Diabetes Mellitus among the Diabetic Patients. Asian J. Nur. Edu. and Research. 2016; 6(2): 171-182.
11. SM Bhanushali, KM Modh, IS Anand, CN Patel, JB Dave. Novel Approaches for Diabetes Mellitus: A Review. Research J. Pharmacology and Pharmacodynamics. 2010; 2(2):141-147.
12. Vidya V Gawande, AV Chandewar. Polypharmacy: An Overview. Research J. Pharm. and Tech. 4 (1): January 2011; Page 155-159.
13. P. Maheshwari, T. S. Shanmugarajan. Evaluation of Prescribing Practices of Metformin in Patients with Type-2 Diabetes Mellitus. Research J. Pharm. and Tech 2019; 12(2):531-534.
14. Abubaker Siddiq, Bharathi DR, Rojin Raj, Janet Benny, Shethal Saji, Sree Lakshmi P. A Study on Insulin use, Prescription Pattern and its Regimens in a Tertiary Care Hospital. Research J. Pharm. and Tech. 2019; 12(5):2079-2082.